Singapore: Regenerative medicine company, Orthocell, has been granted a patent in Canada covering the combination of bio...
Singapore: Bioxyne has entered into a non-binding term sheet for the proposed acquisition of 100 percent of the shares a...
Singapore: Australia-based Clinuvel has developed SCENESSE, its proprietary first-in-class photo protective drug, for in...
Singapore: Sienna Cancer Diagnostics, Melbourne-based biotechnology company focused on developing novel in-vitro diagnos...
Singapore: A novel technology for aiding the diagnosis of Cancers of Unknown Primary (CUP), by Circadian Technologies, w...
Singapore: The Queensland Government has announced a collaboration with the US pharmaceutical and healthcare giant, John...
Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, an...
Singapore: Australia-based Drawbridge Pharmaceuticals has been granted patent for its anesthetic formulation Phaxan in t...
Singapore: Singapore's Inex Innovations Exchange, a fetal health diagnostics company, signed a distribution agreement fo...
There is no doubt that the world is still in a delicate financial balance, with no significant chance of that improving ...
Singapore: Lignol Energy, a leading technology company in the advanced biofuels and renewable chemicals sectors, will in...
Singapore: Nohla Therapeutics, a developer of cellular therapies for haematological disorders and immunological diseases...
Singapore: Australia based TransBio and DendroCyte BioTech have entered into a multi-year collaboration to discover and ...
Innovation, passion and expertise have brought recognition to Cochlear for its niche focus on hearing aids medical devic...
Singapore: Australia's body for supporting health and medical research National Health and Medical Research Council (NHM...
One of Asia Pacific's biggest names in the pharmaceutical industry, CSL, retained its second position in BioSpectrum A...
Singapore: Pharmaceutical company Pharmaxis announced the signing of a financing agreement with NovaQuest Pharma Opport...
Singapore: Innate Immunotherapeutics has raised $8.9 million (AUD10 million) through its Initial Public Offer (IPO) that...
